HUTCHMED (China) Limited ( HCM) - Stock Earnings
HCM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 977500 USD | 135.4 million USD |
| 2026Q1 | 8.0 million USD | 139.1 million USD |
| 2026Q2 | 8.0 million USD | 139.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
HCM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 100.8 million USD | 838.0 million USD |
| 2024 | 37.7 million USD | 630.2 million USD |
| 2025 | 458.1 million USD | 550.0 million USD |
| 2026 Est. | — | — |
HCM
Price: $14.20
52 week price:
Earnings Per Share: 0.10 USD
P/E Ratio: 115.70
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Hong Kong
Volume: 680726
Market Capitalization: 2.5 billion